Suppr超能文献

癌症免疫疗法:对其应用模式的全面评估。

Cancer immunotherapy: A comprehensive appraisal of its modes of application.

作者信息

Hoteit Mira, Oneissi Zeina, Reda Ranim, Wakim Fadi, Zaidan Amar, Farran Mohammad, Abi-Khalil Elie, El-Sibai Mirvat

机构信息

Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut 1102 2801, Lebanon.

出版信息

Oncol Lett. 2021 Sep;22(3):655. doi: 10.3892/ol.2021.12916. Epub 2021 Jul 9.

Abstract

Conventional cancer treatments such as chemotherapy and radiation therapy have reached their therapeutic potential, leaving a gap for developing more effective cancer therapeutics. Cancer cells evade the immune system using various mechanisms of immune tolerance, underlying the potential impact of immunotherapy in the treatment of cancer. Immunotherapy includes several approaches such as activating the immune system in a cytokine-dependent manner, manipulating the feedback mechanisms involved in the immune response, enhancing the immune response via lymphocyte expansion and using cancer vaccines to elicit long-lasting, robust responses. These techniques can be used as monotherapies or combination therapies. The present review describes the immune-based mechanisms involved in tumor cell proliferation and maintenance and the rationale underlying various treatment methods. In addition, the present review provides insight into the potential of immunotherapy used alone or in combination with various types of therapeutics.

摘要

传统的癌症治疗方法,如化疗和放疗,已经达到了它们的治疗潜力,这为开发更有效的癌症治疗方法留下了空白。癌细胞利用各种免疫耐受机制逃避免疫系统,这突出了免疫疗法在癌症治疗中的潜在影响。免疫疗法包括多种方法,如以细胞因子依赖的方式激活免疫系统、操纵免疫反应中涉及的反馈机制、通过淋巴细胞扩增增强免疫反应以及使用癌症疫苗引发持久、强烈的反应。这些技术可以用作单一疗法或联合疗法。本综述描述了肿瘤细胞增殖和维持所涉及的基于免疫的机制以及各种治疗方法的基本原理。此外,本综述还深入探讨了单独使用免疫疗法或与各种类型的治疗方法联合使用的潜力。

相似文献

1
Cancer immunotherapy: A comprehensive appraisal of its modes of application.
Oncol Lett. 2021 Sep;22(3):655. doi: 10.3892/ol.2021.12916. Epub 2021 Jul 9.
3
The potential role of immunotherapy to treat colorectal cancer.
Expert Opin Investig Drugs. 2015 Mar;24(3):329-44. doi: 10.1517/13543784.2015.985376. Epub 2014 Dec 17.
4
Harnessing the immune system to improve cancer therapy.
Ann Transl Med. 2016 Jul;4(14):261. doi: 10.21037/atm.2016.04.01.
5
Emerging trends in the immunotherapy of pancreatic cancer.
Cancer Lett. 2018 Mar 28;417:35-46. doi: 10.1016/j.canlet.2017.12.012. Epub 2017 Dec 12.
6
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
Drug Resist Updat. 2019 Sep;46:100644. doi: 10.1016/j.drup.2019.100644. Epub 2019 Sep 17.
7
On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy.
Front Oncol. 2019 Feb 6;9:50. doi: 10.3389/fonc.2019.00050. eCollection 2019.
8
Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Handb Exp Pharmacol. 2008(181):291-328. doi: 10.1007/978-3-540-73259-4_13.
9
Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.
Cancer Immunol Immunother. 2009 Apr;58(4):475-92. doi: 10.1007/s00262-008-0598-y. Epub 2008 Oct 17.
10
Mechanism of action of immunotherapy.
Semin Oncol. 2014 Oct;41 Suppl 5:S3-13. doi: 10.1053/j.seminoncol.2014.09.004. Epub 2014 Sep 6.

引用本文的文献

1
Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment.
Metabolites. 2024 Dec 5;14(12):683. doi: 10.3390/metabo14120683.
3
Cancer research in Lebanon: Scope of the most recent publications of an academic institution (Review).
Oncol Lett. 2024 Jun 3;28(2):350. doi: 10.3892/ol.2024.14484. eCollection 2024 Aug.
4
The future of affordable cancer immunotherapy.
Front Immunol. 2023 Sep 6;14:1248867. doi: 10.3389/fimmu.2023.1248867. eCollection 2023.
7
Identifying health research in the era of COVID-19: A scoping review.
SAGE Open Med. 2023 Jun 8;11:20503121231180030. doi: 10.1177/20503121231180030. eCollection 2023.
8
An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies.
Cancer Inform. 2023 Feb 1;22:11769351221150772. doi: 10.1177/11769351221150772. eCollection 2023.
9
Activated T cell therapy targeting glioblastoma cancer stem cells.
Sci Rep. 2023 Jan 5;13(1):196. doi: 10.1038/s41598-022-27184-w.
10
Novel Tumor-Targeting Nanoparticles for Cancer Treatment-A Review.
Int J Mol Sci. 2022 May 8;23(9):5253. doi: 10.3390/ijms23095253.

本文引用的文献

1
Cancer Vaccines, Adjuvants, and Delivery Systems.
Front Immunol. 2021 Mar 30;12:627932. doi: 10.3389/fimmu.2021.627932. eCollection 2021.
2
Immune response drives outcomes in prostate cancer: implications for immunotherapy.
Mol Oncol. 2021 May;15(5):1358-1375. doi: 10.1002/1878-0261.12887. Epub 2020 Dec 29.
3
DC-Based Vaccines for Cancer Immunotherapy.
Vaccines (Basel). 2020 Nov 26;8(4):706. doi: 10.3390/vaccines8040706.
4
Next-generation cell therapies: the emerging role of CAR-NK cells.
Blood Adv. 2020 Nov 24;4(22):5868-5876. doi: 10.1182/bloodadvances.2020002547.
5
Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
Hum Vaccin Immunother. 2021 May 4;17(5):1288-1293. doi: 10.1080/21645515.2020.1823778. Epub 2020 Nov 11.
7
Monoclonal Antibodies in Cancer Therapy.
Antibodies (Basel). 2020 Jul 20;9(3):34. doi: 10.3390/antib9030034.
9
Comparison of DNA and mRNA vaccines against cancer.
Drug Discov Today. 2020 Mar;25(3):552-560. doi: 10.1016/j.drudis.2019.12.003. Epub 2019 Dec 13.
10
Monoclonal Antibodies: Past, Present and Future.
Handb Exp Pharmacol. 2019;260:81-141. doi: 10.1007/164_2019_323.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验